Verde Bio enters $6M Series C Preferred financing with GHS Investments

VERDE BIO HOLDINGS, INC.

Initial close of 125 preferred shares at $1,000 each, raising $125,000; total up to 6,000 shares ($6M).
200 commitment shares issued pro-rata; 8% annual dividend payable quarterly in cash or stock.
Amended Certificate of Designation increases authorized Series C shares to 7,600.
Additional closings of 250 shares each subject to equity conditions (price >$0.005, volume >$60K/day).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.